Clinical trial
Cardiovascular Risk Markers and Response to Statins After Kawasaki Disease
NCT00305201 · Pontificia Universidad Catolica de Chile, Other · Withdrawn
Key facts
| NCT number | NCT00305201 |
|---|---|
| Title | Cardiovascular Risk Markers and Response to Statins After Kawasaki Disease |
| Official title | Cardiovascular Risk Markers Before and After Therapy With Statins in Patients With History of Kawasaki Disease |
| Lead sponsor | Pontificia Universidad Catolica de Chile, Other |
| Collaborators | Bristol-Myers Squibb Industry |
| Status | Withdrawn |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Kawasaki Disease |
| Intervention type | Drug |
| Interventions | pravastatin |
| Enrollment | 0 |
| Start date | Apr 1, 2006 |
| Completion | May 1, 2007 |
| First posted | Mar 21, 2006 |
| Last update posted | May 24, 2016 |
| Countries | Chile |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: